Background COVID-19 infection can show various manifestation, including neurologic
manifestations, such as anosmia, ageusia, or dysgeusia, and causes the neurologic …

Background Accumulating evidence on the neurological sequelae of COVID-19 is a serious
concern, with patients possibly being at risk of permanent debilitation if not managed …

Background The COVID-19 pandemic has drastically affected everyone in a hit or miss
manner. Since it began, evidence of the neuro-invasive potential of the virus has been …

Background COVID–19 infection has spread so fast in both low–and high–income countries.
In December 2019, an outbreak of a respiratory disease occurred in China, and later, it …

The Coronavirus disease due to SARS-CoV-2 emerged in Wuhan city, China in December
2019 and rapidly spread to more than 200 countries as a global health pandemic. There are …

Background The coronavirus disease due to SARS COVID-2 emerged from Wuhan city in
China in December 2019 and rapidly spread to more than 200 countries all over the world …

Background: Growing evidence showed that coronavirus disease 2019 (COVID-19) infection
may present with neurological manifestations. This review aimed to determine the …

Background: Though reports of neurological manifestations of COVID-19 have emerged
from various parts of the world, the cohorts reported are from the West and mostly derived …

Background: Neurological manifestations have increasingly become recognized in COVID-
19. People from different ethnic backgrounds are experiencing different outcomes related to …

Background Neurological involvements of COVID-19 are one of the most reported
manifestations of this infection. This study aims to systematically review the previous …